U-Chart Analysis:Astellas Pharma Inc.:4503

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Astellas Pharma Inc. Go to web site 4503 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Astellas Pharma Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Balance Sheet 2023年3月期 Astellas Pharma Inc. Balance Sheet 2022年3月期 Astellas Pharma Inc. Balance Sheet 2021年3月期 Astellas Pharma Inc. Balance Sheet 2020年3月期 Astellas Pharma Inc. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 376,840 315,986 326,128 318,391 311,074
Other Current AssetsHelp 673,114 607,368 546,460 549,123 546,085
Tangible Fixed AssetsHelp 286,459 269,044 264,623 268,600 173,483
Intangible Fixed AssetHelp 562,496 623,431 651,427 724,773 429,707
Investments and OthersHelp 229,198 213,536 200,979 176,029 211,435
Total AssetsHelp 2,456,518 2,332,395 2,273,628 2,315,169 1,897,648
Total Current LiabilitiesHelp 808,640 776,201 688,492 896,729 586,370
Total Long-term LiabilitiesHelp 139,924 95,886 199,021 129,272 52,882
Shareholder's EquityHelp 1,507,954 1,460,308 1,386,115 1,289,168 1,258,396
Total LiabilitiesHelp 2,456,518 2,332,395 2,273,628 2,315,169 1,897,648

Astellas Pharma Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Profit and Loss Account 2023年3月期 Astellas Pharma Inc. Profit and Loss Account 2022年3月期 Astellas Pharma Inc. Profit and Loss Account 2021年3月期 Astellas Pharma Inc. Profit and Loss Account 2020年3月期 Astellas Pharma Inc. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 1,518,619 1,296,163 1,249,528 1,300,843 1,306,348
Total Sales 1,518,619 1,296,163 1,249,528 1,300,843 1,306,348
Cost of SalesHelp 288,353 253,009 246,063 276,739 292,050
Other Costs and RevenueHelp 1,131,552 919,068 882,875 828,693 792,033
Total CostsHelp 1,419,905 1,172,077 1,128,938 1,105,432 1,084,083
Net RevenueHelp 1,230,266 1,043,154 1,003,465 1,024,104 1,014,298
Earnings Before TaxHelp 132,361 156,886 145,324 245,350 248,967
Net IncomeHelp 98,714 124,086 120,590 195,411 222,265
Net Income 98,714 124,086 120,590 195,411 222,265

Astellas Pharma Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Astellas Pharma Inc. Cash Flow Statement 2023年3月期 Astellas Pharma Inc. Cash Flow Statement 2022年3月期 Astellas Pharma Inc. Cash Flow Statement 2021年3月期 Astellas Pharma Inc. Cash Flow Statement 2020年3月期 Astellas Pharma Inc. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 327,767 257,443 306,843 221,997 256,899
Investing Cash Flow(ICF)Help -84,500 -62,413 -81,894 -389,793 -41,757
Financing Cash FlowHelp -195,623 -216,298 -229,479 181,055 -233,681
Exchange Difference of Cash and Cash EquivalentsHelp 13,210 11,125 12,267 -5,942 -2,118
Net Increase and Decrease in Cash and Cash Equivalentsn 60,854 -10,143 7,737 7,317 -20,657

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Astellas Pharma Inc.

Company where related level is highHelp

R-TECH UENO,LTD.
RIBOMIC Inc.
MORISHITA JINTAN CO.,LTD.
Perseus Proteomics Inc.
LTT Bio-Pharma Co.,Ltd.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
JCR Pharmaceuticals Co.,Ltd.
Tsubota Laboratory Incorporated
BrightPath Biotherapeutics Co., Ltd.
TMS Co.,Ltd.